NEW YORK (Reuters Health) - A drug used to treat the symptoms of psychosis in patients with schizophrenia and bipolar disorder may also be a useful medication for individuals who are addicted to ...
Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control of ...
(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck. World Mental Health Day, observed on October 10, is a time to raise awareness, reduce stigma, and provide ...
Erin Crown, PA-C, CAQ-Psychiatry is a paid consultant of ®2024 Otsuka America Pharmaceutical, Inc. and Lundbeck, manufacturers of ABILIFY ASIMTUFII ® (aripiprazole) and ABILIFY MAINTENA ® ...
ABILIFY MAINTENA® (aripiprazole). Please see IMPORTANT SAFETY INFORMATION, including BOXED WARNING for INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS, for ABILIFY ASIMTUFII ...
Pdoc decided to transition me from AdderallXR to Abilify last Wednesday. Gave me a taper off schedule that had me off AdderallXR by Sunday and starting Abilify on Monday.<BR><BR>Saturday morning I was ...
NEW YORK, May 21 (Reuters) - Bristol-Myers Squibb Co.'s schizophrenia drug Abilify proved effective as an add-on therapy for patients suffering from major depression who were not getting satisfactory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback